NPB delivered its debut quarterly results as a public company this week, and the most interesting tension now is whether the stock's post-print positioning aligns with what the numbers showed.
Short interest is low in absolute terms but has been moving in a clear direction. At 1.2% of the free float, the short base is modest — but it climbed 13% on the week, reversing a month-long decline that had taken it down roughly 16%. That weekly rebuild is worth noting on a stock this lightly traded. Borrow conditions remain extremely loose: availability is running at over 5,000% — meaning there are nearly 27 shares available to lend for every one currently borrowed — so the short interest uptick reflects fresh conviction, not a technical squeeze risk. Cost to borrow has eased sharply too, falling almost 29% on the week to around 1.1%, near its lowest levels of the past six weeks. The borrow market is effectively open for anyone who wants to press the short side.
The Street setup heading into earnings was constructive, and has been building steadily since IPO. Piper Sandler lifted its target to $22 earlier this month — the fifth consecutive increase from that firm, ratcheting from $16.50 at initiation in March 2025 all the way to where it sits now. The mean target across the thin coverage universe is $21.25, roughly 14% above Tuesday's close of $18.71. Janney Montgomery Scott initiated at Neutral with a $19.25 target back in August 2025, providing a counterweight to Piper's consistent enthusiasm. The valuation picture is equally grounded: NPB trades at 6.6x trailing earnings and just below book value at 0.95x price-to-book — a discount that bulls argue reflects IPO-era uncertainty rather than fundamental weakness. Factor scores are unremarkable across most dimensions, though the dividend score ranks in the 72nd percentile, above average for its peer group in regional banking.
The ownership picture tells a story of serious institutional engagement for a stock this young. Wellington Management holds 13% of shares and added nearly 1.9 million shares in the quarter ending March 31. Adage Capital added 583,000 shares in the same period. Boston Partners entered with a near-full position build of 1.17 million shares by April. Against that institutional buying, independent director David Hooker sold around 15,000 shares across multiple transactions between June and early July — all at prices between $17.50 and $19.30, locking in gains as the stock approached analyst targets. The net insider position over the past 90 days actually shows a positive 72,500 shares, partly reflecting the complexity of founder and executive holdings from larger names like John Simoni (8.9% holder) adding 488,000 shares through June.
Close peers put NPB's week in perspective. MBWM gained 4.6% on the week and BWFG added 3.1%, both outpacing NPB's 0.4% weekly gain — suggesting the broader regional bank tone was positive, and NPB's muted move into and out of its earnings print was more of a hold than a rally. The next quarterly event is flagged for late October, which means the next several weeks shift from earnings-event mode to execution mode: how quickly origination balances build toward that $3.3–3.5 billion year-end target is the metric to watch.
See the live data behind this article on ORTEX.
Open NPB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
